As host and head of content for Radio Advisory, Rachel (also known as “Rae”) plans and prioritizes episodes based on the most pressing challenges of the day. As host, Rae interviews industry experts, breaking down the top issues executives should be thinking about and eliciting the actionable next steps healthcare leaders should take.
Rachel (Rae) Woods has hosted 191 Episodes.
-
233: Your digital strategy needs more than “change management”
December 3rd, 2024 | 29 mins 59 secs
leadership, tech and ai
In this episode, the first of a two-part series on managing digital change, host Rachel Woods has a conversation with Advisory Board digital health expert John League and Optum Advisory Vice President of Digital Transformation Matt Matousek about the pitfalls of the term “change management” and what’s needed to successfully guide your organization through digital transformation.
-
230: Elections results are in: What healthcare leaders need to know
November 12th, 2024 | 45 mins 10 secs
clinical innovation and affordability, leadership, provider strategy and financial outlook
The 2024 elections are over. In this episode, hosts Rachel Woods and Abby Burns invite Advisory Board experts Natalie Trebes and Ben Palmer to break down what healthcare leaders can anticipate under incoming federal and state leadership bodies, what impacts new leadership is likely to have on key issue areas like the ACA, Medicaid, drug pricing, abortion, and more, and what we will be watching for in the days, weeks, and months to come. And, of course, what it all means for you, our listeners.
-
229: Live from HLTH: What Can’t GLP-1s Do?
November 5th, 2024 | 41 mins 36 secs
clinical innovation and affordability, external guests, provider strategy and financial outlook
In this episode, recorded live from HLTH 2024, host Rae Woods sits down with Calibrate CEO Rob MacNaughton, Real Chemistry President of Transformative Healthcare Markets Rita Glaze-Rowe, and physician founder, Dr. Spencer Nadolsky, to break down both the optimism and pessimism surrounding GLP-1s, as well as their limitations. In a market that is buzzing around the novel medications, these experts suggest a new focus on comprehensive weight management programs.
-
228: Avoiding ‘pilot purgatory’ in remote patient monitoring
October 29th, 2024 | 23 mins 30 secs
clinical innovation and affordability, provider strategy and financial outlook, tech and ai
In this episode, host Rachel Woods invites Advisory Board experts Lauren Woodrow and Kristin Strubel to unpack the unseen promise of remote patient monitoring (RPM). Together, they explain why most RPM programs aren’t being used to their full potential and share steps leaders can take to optimize their RPM technologies, regardless of what stage of adoption they are in.
-
227: The changing tide of Medicare Advantage
October 22nd, 2024 | 20 mins 29 secs
physician landscape, provider strategy and financial outlook
Hosts Rachel Woods and Abby Burns sit down with Advisory Board health plan experts Max Hakanson and Chelsea Needham to make sense of the challenges and changes in the Medicare Advantage market.
-
224: The $400M referral problem (and steps to fixing it)
October 1st, 2024 | 24 mins 56 secs
physician landscape, provider strategy and financial outlook
This week, host Rachel (Rae) Woods invites Advisory Board physician experts Eliza Dailey and Colleen Wagner to unpack where referral leakage actually happens and share the real (and relatively easy) steps organizations can take to reduce referral leakage.
-
216: Why providers and employers need to focus on women's health "beyond the bikini"
July 16th, 2024 | 28 mins 10 secs
health equity, service lines
In this episode, host Rachel Woods invites Advisory Board women’s health experts Kara Marlatt and Gaby Marmolejos to explain why providers and employers need to expand their focus on women’s health to include the post-reproductive years, and explore what tangible steps they can take to do so today.
-
Behind the scenes: Our journey to four years, 1M downloads
July 2nd, 2024 | 31 mins 29 secs
Host Rachel Woods and the Radio Advisory production team celebrate one million downloads by looking back at some of their favorite episodes and the lessons learned along the way.
-
214: Is Governance the answer to AI integration? Duke says yes.
June 25th, 2024 | 31 mins 32 secs
external guests, provider strategy and financial outlook, tech and ai
In this episode, host Rachel Woods invites Duke University Health System's Chief Information Officer, Dr. Eric Poon, to discuss how Duke has approached the ethical implementation of AI across and why the right governance structure is essential.
-
211: Pursuing financial sustainability in cell and gene therapy delivery
June 4th, 2024 | 28 mins 41 secs
clinical innovation and affordability, provider strategy and financial outlook
The conversation around cell and gene therapies often centers on payers and purchasers, and the challenge of financing access to these expensive treatments. But there’s a key stakeholder missing from that discussion: the providers. In the final episode of our series on bespoke care and innovation, host Rachel Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to highlight the delivery side of the equation and unpack how providers are grappling with how to get these life-changing treatments to those that need them: patients.
-
210: How you approach precision medicine matters—for some patients more than others
May 28th, 2024 | 31 mins 43 secs
clinical innovation and affordability, health equity
In this episode, host Rachel Woods invites Advisory Board clinical innovation experts Amanda Okaka and Fanta Cherif to break down the health equity conundrum presented by precision medicine: Will precision medicine reduce disparities, or exacerbate them? The answer depends on the actions—big and small—of industry leaders.
-
209: Predicting what oncology will look like in 2030
May 21st, 2024 | 30 mins 43 secs
service lines
In this episode, host Rachel Woods invites Advisory Board specialty care experts Lindsey Paul and Julia Elder to discuss what the future of cancer care will look like and what changes the industry needs to make in order to prepare.